Federal Income Tax Problems in Corporate Reorganizations, Exchanges, and Distributions and Statutory Tax Postponements and Exemptions in Statutes Administered by the Securities and Exchange Commission.
Files in this item
Dvoret, Mitchell S.
Showing items related by title, author, creator and subject.
Conspiracy of Silence: How the FDA Allows Drug Companies to Abuse the Accelerated Approval Process. Staff Summary of Responses by the Food and Drug Administration and the Securities and Exchange Commission to Correspondence From Rep. Edward J. Markey (D-MA), Senior Member, Energy and Commerce Committee, U.S. House of Representatives Unknown author (United States. House of Representatives. Energy and Commerce Committee, 2005-06)